INS and Insulin resistance: Ceramides decrease the plasma content during pioglitazone treatment, and inhibition of ceramide synthesis or stimulation of ceramide degradation improves insulin signaling, indicating indispensable participation of ceramides in the development of obesity and insulin resistance [189].